HCA
HALO icon

Harbor Capital Advisors’s Halozyme HALO Stock Holding History

Harbor Capital Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.03M Buy
+31,355
New +$2.21M 0.16% 182
2025
Q3 		– Sell
-309
Closed -$16K – 1402
2025
Q2 		$16K Sell
309
-27
-8% -$1.54K ﹤0.01% 835
2025
Q1 		$21K Buy
336
+92
+38% +$5.34K ﹤0.01% 798
2024
Q4 		$12K Buy
244
+13
+6% +$667 ﹤0.01% 912
2024
Q3 		$13K Buy
+231
New +$13.2K ﹤0.01% 896

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harbor Capital Advisors's HALO Position: Q1 2026 in Review

Harbor Capital Advisors opened a new position in Halozyme (HALO) in Q1 2026: 31,355 shares worth $2.03M. The stake represents 0.16% of the portfolio and ranks #182 among its holdings. This is a return to the name: Harbor Capital Advisors previously reported a position in HALO as recently as Q2 2025.

Harbor Capital Advisors first reported a position in HALO in Q3 2024 and has held it in 5 quarters since. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Harbor Capital Advisors held 31,355 shares of Halozyme worth $2.03M as of Q1 2026.
  • Halozyme was a new Harbor Capital Advisors position in Q1 2026.
  • Halozyme made up 0.16% of Harbor Capital Advisors's portfolio in Q1 2026, its #182 holding.
  • Harbor Capital Advisors first reported a position in Halozyme in Q3 2024 and has held it in 5 quarters since.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.